Hao Chen is the Associate Vice President in the Process R&D organization at Merck & Co., Inc. He leads the process development and clinical manufacturing for Merck’s vaccines and advanced biotechnology pipeline, spanning all major vaccine modalities from mRNA and recombinant proteins to polysaccharide conjugates and live viral vaccines. Hao joined Merck in 2009 with increasing responsibilities in R&D and later commercial manufacturing for biologics development and commercialization till 2018. He then joined GSK Vaccines in Belgium to lead the global drug substance development and in-process analytics for mRNA as well as cell and viral based vaccines. In his early career, Hao worked on upstream process development in various other companies including Amylin Pharmaceuticals and Becton Dickinson. Hao received his MS/BS in Chemical Engineering at Zhejiang University, PhD in Chemical Engineering at Purdue University, and Executive MBA at HEC Paris.
